MDAI

MDAI
MDAI
5,6-Methylenedioxy-2-aminoindane (MDAI) is a drug developed in the 1990s
by a team led by David E. Nichols at Purdue University. It acts as a 
non-neurotoxic and highly selective serotonin releasing agent (SSRA) in
vitro and produces mild entactogen effects in humans. 
Medicines Intermediates 2-AI 4-FA 
4-FMC 4-MEC 
4-MEA 5-IAI 
AMT 5_MeO_AMT 
5_MeO_DMT BUTTYLONE 
METHYLONE NRG-1 
MDAI MDPV 
M1-2 METH 
PV1-2 AM694 
AM-2201  

Product Origin:  
Model Number:  
Brand Name:  
   
   

Contact UsMSN chat with us

Company Name: Hubei Danjiangkou Kaitai Hormone Co., Ltd.,
Contact Person: kevin
Address: North of Yaogou Rd., Danjiangkou city, Hubei prov. China
Zip: 442700
Telephone: 0086-15527204446
Fax: 0086-88048077
E-mail: kvnchem@gmail.com
Website: http://kvnchem.tradeee.com

Send Inquiry

Your Name:
Email:
Your Company:
Country/Area:
Content:
CAPTCHA:
CAPTCHA Image Load new image